<?xml version="1.0" encoding="UTF-8" ?><rss version="2.0"><channel><title>Strumors - Healthcare</title><description>Strumors - Healthcare</description><link>http://strumors.com/sector/healthcare</link><item><title>Pfizer Looking to Buy</title><link>http://strumors.com/953</link><description>Pfizer who is currently sitting on $25 billion in cash is looking to acquire biotech companies on the cheap.  The company has recently done two $200 million acquisitions and is now looking to acquire more companies who might be on the verge of producing the next big vaccine.</description><pubDate>Tue, 04 Dec 2007 16:01:09 -0500</pubDate><guid>http://strumors.com/953</guid></item><item><title>Glaxo to Acquire Reliant Pharmaceuticals for $1.65 Billion</title><link>http://strumors.com/401</link><description>GlaxoSmithKline has agreed to acquire Reliant Pharmaceuticals for $1.65 billion in cash.  The move is expected to increase its drug sales in the U.S.  Glaxo has had a rough couple of months after slowing sales of its core diabetes drug Avandia, following a report linking the drug to increased heart-attack risks.  </description><pubDate>Wed, 01 Nov 2006 21:01:05 -0500</pubDate><guid>http://strumors.com/401</guid></item><item><title>Eli Lilly Launches Type 2 Diabetes Treatment, Byetta, in India</title><link>http://strumors.com/394</link><description>Eli Lilly and Company India launced an injection treatment named Byetta aimed to improve blood sugar control for patients with type 2 diabeties in India.  Byetta is not a replacement for insulin; instead, Byetta is designed to help the body make more of its own insulin.  India is now the fourth major market to have Byetta approved, following successful launches in the US, UK, and Germany.</description><pubDate>Wed, 01 Nov 2006 19:02:01 -0500</pubDate><guid>http://strumors.com/394</guid></item><item><title>Biogen Up for Sale</title><link>http://strumors.com/282</link><description>Biogen Idec is considering buyout offers after billionaire investor Carl Icahn and other potential buyers have expressed interest in acquiring the company.  Biogen is one of the largest biotechnology companies that has been dealing with slowing growth for its primary product, a multiple sclerosis drug, Avonex.</description><pubDate>Tue, 31 Oct 2006 13:01:02 -0500</pubDate><guid>http://strumors.com/282</guid></item><item><title>Quest Diagnostics CFO, Robert Hagemann, Sold 12,502 Shares.</title><link>http://strumors.com/116</link><description>Robert Hagemann, CFO of Quest Diagnostics, sold 12,502 shares of common stock on Friday.</description><pubDate>Fri, 08 Dec 2006 01:01:07 -0500</pubDate><guid>http://strumors.com/116</guid></item><item><title>Moody's reduces Boston Scientific rating to Junk Status</title><link>http://strumors.com/115</link><description>Moody's downgraded Boston Scientific to junk status citing poor Q2 performance.</description><pubDate>Fri, 08 Dec 2006 01:01:07 -0500</pubDate><guid>http://strumors.com/115</guid></item><item><title>St. Judes gets FDA Approval for Heart Access Device</title><link>http://strumors.com/114</link><description>St. Jude reported Thursday that the U.S. Food and Drug Administration approved their new heart access device for use during cardiac procedures.</description><pubDate>Fri, 08 Dec 2006 01:01:07 -0500</pubDate><guid>http://strumors.com/114</guid></item><item><title>UBS Sticks with Buy Rating for Celgene</title><link>http://strumors.com/113</link><description>UBS reiterated its buy rating for Celgene with a price target of $75.</description><pubDate>Fri, 08 Dec 2006 01:01:07 -0500</pubDate><guid>http://strumors.com/113</guid></item><item><title>Kyphon Bought by Medtronic</title><link>http://strumors.com/112</link><description>Medtronics purchased Kyphon for $3.9 billion.  Kyphon specializes in devices for treating spinal disorders.</description><pubDate>Fri, 08 Dec 2006 01:01:06 -0500</pubDate><guid>http://strumors.com/112</guid></item><item><title>Avastin a Cancer Drug Generates Higher Revenues for Genentech</title><link>http://strumors.com/111</link><description>Genentec posted a 41% increase in revenues partly due to a 33% increase in Avastin sales.  Avastin fights several forms of lung, breast, and colon cancer.</description><pubDate>Fri, 08 Dec 2006 01:01:06 -0500</pubDate><guid>http://strumors.com/111</guid></item><item><title>Amgen Drops on Medicare concerns</title><link>http://strumors.com/110</link><description>Shares of Amgen dropped for a second day as the Centers for Medicare and Medicaid Services announced more stricter guidelines for medical reimbursements of Amgen's top selling drugs Aranesp and Epogen.</description><pubDate>Fri, 08 Dec 2006 01:01:06 -0500</pubDate><guid>http://strumors.com/110</guid></item><item><title>Merck CFO, Judy C. Lewent, sells shares</title><link>http://strumors.com/109</link><description>Judy C. Lewent the CFO of Merck sold 50,000 shares of common stock on Thursday.</description><pubDate>Fri, 08 Dec 2006 01:01:06 -0500</pubDate><guid>http://strumors.com/109</guid></item><item><title>Study Confirms Positive Effect of Treatment for Alzheimer's</title><link>http://strumors.com/86</link><description>A multinational study sponsored by Pfizer reported positive effects for the treatment of Alzheimer's.</description><pubDate>Fri, 08 Dec 2006 06:01:07 -0500</pubDate><guid>http://strumors.com/86</guid></item><item><title>Johnson and Johnson is going to reduce their laborforce at lititz facility.</title><link>http://strumors.com/35</link><description>Johnson &amp; Johnson announced that they are cutting their workforce at the lititz facility by 300 to 340 positions as its ongoing effort to remain competitive in the marketplace.</description><pubDate>Fri, 08 Dec 2006 05:01:04 -0500</pubDate><guid>http://strumors.com/35</guid></item></channel></rss>